nnc 0151-0000-0000
mAbexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2008 (NCT02151409)
Timeline
Indications
Mechanism of action
C5AR1 inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- nnc 0151-0000-0000
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01223911 | Phase 2 | Jan 1, 2011 | Novo Nordisk |
| NCT01018238 | Phase 1 | Nov 1, 2009 | Novo Nordisk |
| NCT02151409 | Phase 1 | Jun 1, 2008 | Novo Nordisk |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Novo Nordisk | For profit | 3 | 3 | 2 | 2008 |
1 organizations
Page 1 / 1